Riskpilot← Back to searchSign inGet full accessXmedic AB
ABActiveOrg 5568196181Göingegatan 4Research and experimental development on natural sciences and engineering · NACE 7210Est. 20100 employees
Revenue 2024
SEK 38K
EBITDA margin
57.8%
+249% vs 2023
Equity ratio
11.1%
Financial strength
Net profit 2024
SEK -1K
+99% vs 2023
| Revenue | SEK 38K | — |
| EBITDA | SEK 22K | +249% |
| Net profit | SEK -1K | +99% |
| Total assets | SEK 867K | +1% |
| Equity | SEK 96K | -1% |
| Employees | 0 | — |
Legal name
Xmedic AB
Org number
5568196181
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
22 september 2010
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva konsulttjänster inom medicinsk forskning och utveckling, äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Göingegatan 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 110 | 0 | 0 | 0 | 0 | 38 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −52 | 61 | 52 | 129 | 90 | −13 | −22 | −12 | −15 | 22 |
| Depreciation & amort. | −3 | −3 | −3 | −3 | −0 | −0 | −0 | — | — | — |
| EBIT | −55 | 58 | 49 | 126 | 90 | −13 | −22 | −12 | −15 | 22 |
| Net financials | 365 | 1 198 | 169 | 103 | 1 524 | 117 | −69 | −214 | −82 | −15 |
| Profit before tax | 130 | 1 053 | 163 | 171 | 2 160 | 104 | −50 | −226 | −96 | 6 |
| Tax | −126 | −134 | −36 | −39 | −272 | −22 | −0 | — | — | −8 |
| Net profit | 4 | 919 | 127 | 132 | 1 888 | 82 | −50 | −226 | −96 | −1 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 030 | 3 190 | 3 298 | 3 496 | 2 144 | 1 208 | 1 201 | 952 | 856 | 867 |
| Equity | 1 365 | 2 284 | 2 411 | 2 543 | 1 938 | 140 | 90 | 93 | 97 | 96 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — |
| Short-term debt | 478 | 516 | 442 | 450 | 206 | 1 069 | 1 111 | 859 | 759 | 771 |
| Total debt | 478 | 516 | 442 | 450 | 206 | 1 069 | 1 111 | 859 | 759 | 771 |
EBITDA margin
57.8%
This company
15.8%
Market median
+266% vs market
20152024
Equity ratio
11.1%
This company
38.2%
Market median
-71% vs market
20152024
Return on equity
-1.3%
This company
18.4%
Market median
-107% vs market
20152024
Net profit margin
-3.3%
This company
8.1%
Market median
-141% vs market
20152024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20152024
Debt / equity
8.02×
This company
0.62×
Market median
-1194% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BU | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Xmedic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bertil Ulf Moritz Raue | Audit | 0 companies |
| Maria Helene Lilian Hartman | Board of Directors | 0 companies |
| Bo Ture David Benell | Deputy Board Member | 0 companies |
| Artur Schmidtchen | Chairman | 0 companies |